Ubs Group Ag Sab Biotherapeutics Inc Wt Exp Transaction History

Ubs Group Ag

$611 Billion
Q3 2025

A detailed history of Ubs Group Ag transactions in Sab Biotherapeutics Inc Wt Exp stock. As of the latest transaction made, Ubs Group Ag holds 23,414 shares of SABSW stock, worth $702. This represents 0.0% of its overall portfolio holdings.

Number of Shares

23,414

Holding current value

$702

% of portfolio

0.0%

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	BUY	$0.02 - $0.06 $468 - $1,404	23,414 New	23,414 $0
Q4 2024 Feb 14, 2025	BUY	$0.03 - $0.1 $48 - $163	1,633 New	1,633 $0
Q2 2024 Aug 13, 2024	BUY	$0.02 - $0.07 $1 - $3	56 New	56 $0
Q4 2023 Feb 09, 2024	BUY	$0.03 - $0.1 $872 - $2,908	29,080 New	29,080 $0
Q2 2023 Aug 11, 2023	BUY	$0.04 - $0.16 $4 - $16	100 New	100 $0
Q3 2022 Nov 10, 2022	BUY	$0.05 - $0.22 $280 - $1,233	5,606 New	5,606 $0
Q1 2022 May 16, 2022	SELL	$0.22 - $1.87 $635 - $5,400	-2,888 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$0.95 - $3.0 $2,743 - $8,664	2,888 New	2,888 $5,000

Others Institutions Holding SABSW

# of Institutions

Shares Held

928K

Call Options Held

62.5K

Put Options Held

View Full List

About SAB BIOTHERAPEUTICS INC WT EXP

Ticker SABSW
Sector Healthcare
Industry Biotechnology

More about SABSW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account